These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22823162)

  • 21. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
    Deliyannis G; Kedzierska K; Lau YF; Zeng W; Turner SJ; Jackson DC; Brown LE
    Eur J Immunol; 2006 Mar; 36(3):770-8. PubMed ID: 16435281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic efficacy of Hypericum perforatum L. extract for mice infected with an influenza A virus.
    Xiuying P; Jianping L; Ruofeng S; Liye Z; Xuehong W; Yan L
    Can J Physiol Pharmacol; 2012 Feb; 90(2):123-30. PubMed ID: 22260349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokine regulation of the inflammatory response to a low-dose influenza infection in CCR2-/- mice.
    Wareing MD; Lyon A; Inglis C; Giannoni F; Charo I; Sarawar SR
    J Leukoc Biol; 2007 Mar; 81(3):793-801. PubMed ID: 17179466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
    Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
    J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses.
    Kawashima T; Hayashi K; Kosaka A; Kawashima M; Igarashi T; Tsutsui H; Tsuji NM; Nishimura I; Hayashi T; Obata A
    Int Immunopharmacol; 2011 Dec; 11(12):2017-24. PubMed ID: 21893216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APRIL affects antibody responses and early leukocyte infiltration, but not influenza A viral control.
    Hardenberg G; van der Sluijs K; van der Poll T; Medema JP
    Mol Immunol; 2008 Jun; 45(11):3050-8. PubMed ID: 18471884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of oral administration of heat-killed probiotics from Mongolian dairy products against influenza infection in mice: alleviation of influenza infection by its immunomodulatory activity through intestinal immunity.
    Takeda S; Takeshita M; Kikuchi Y; Dashnyam B; Kawahara S; Yoshida H; Watanabe W; Muguruma M; Kurokawa M
    Int Immunopharmacol; 2011 Dec; 11(12):1976-83. PubMed ID: 21871585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
    Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
    J Immunol; 1996 May; 156(10):3892-900. PubMed ID: 8621928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Fang F; Zheng M; Chen Z
    Vaccine; 2010 Nov; 28(48):7690-8. PubMed ID: 20870054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
    Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y
    Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.
    Cluff CW; Baldridge JR; Stöver AG; Evans JT; Johnson DA; Lacy MJ; Clawson VG; Yorgensen VM; Johnson CL; Livesay MT; Hershberg RM; Persing DH
    Infect Immun; 2005 May; 73(5):3044-52. PubMed ID: 15845512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleotide oligomerization and binding domain 2-dependent dendritic cell activation is necessary for innate immunity and optimal CD8+ T Cell responses to influenza A virus infection.
    Lupfer C; Thomas PG; Kanneganti TD
    J Virol; 2014 Aug; 88(16):8946-55. PubMed ID: 24872587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.
    Stifter SA; Bhattacharyya N; Pillay R; Flórido M; Triccas JA; Britton WJ; Feng CG
    PLoS Pathog; 2016 Jan; 12(1):e1005378. PubMed ID: 26731100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs.
    Deliyannis G; Wong CY; McQuilten HA; Bachem A; Clarke M; Jia X; Horrocks K; Zeng W; Girkin J; Scott NE; Londrigan SL; Reading PC; Bartlett NW; Kedzierska K; Brown LE; Mercuri F; Demaison C; Jackson DC; Chua BY
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33561017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type I Interferon Induced Epigenetic Regulation of Macrophages Suppresses Innate and Adaptive Immunity in Acute Respiratory Viral Infection.
    Kroetz DN; Allen RM; Schaller MA; Cavallaro C; Ito T; Kunkel SL
    PLoS Pathog; 2015 Dec; 11(12):e1005338. PubMed ID: 26709698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells.
    Skabytska Y; Wölbing F; Günther C; Köberle M; Kaesler S; Chen KM; Guenova E; Demircioglu D; Kempf WE; Volz T; Rammensee HG; Schaller M; Röcken M; Götz F; Biedermann T
    Immunity; 2014 Nov; 41(5):762-75. PubMed ID: 25456159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.
    LeMessurier KS; Lin Y; McCullers JA; Samarasinghe AE
    Antiviral Res; 2016 Sep; 133():208-17. PubMed ID: 27531368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pam3CSK(4) enhanced beta cell loss and diabetogenesis: the roles of IFN-gamma and IL-17.
    Al Shamsi M; Shahin A; Iwakura Y; Lukic ML; Mensah-Brown EP
    Clin Immunol; 2013 Oct; 149(1):86-96. PubMed ID: 23899994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.